101 related articles for article (PubMed ID: 14571807)
21. [Intra-tumoral injection therapy in patients with hepatocellular carcinoma].
Watanabe S; Kagawa H; Shirai M; Nishioka M
Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 2):1635-41. PubMed ID: 3015038
[TBL] [Abstract][Full Text] [Related]
22. A critical appraisal of the literature on local ablative therapies for hepatocellular carcinoma.
Lencioni R; Crocetti L
Clin Liver Dis; 2005 May; 9(2):301-14, viii. PubMed ID: 15831275
[TBL] [Abstract][Full Text] [Related]
23. Percutaneous ablation of hepatocellular carcinoma: state-of-the-art.
Lencioni R; Cioni D; Crocetti L; Bartolozzi C
Liver Transpl; 2004 Feb; 10(2 Suppl 1):S91-7. PubMed ID: 14762847
[TBL] [Abstract][Full Text] [Related]
24. Thoracoscopic ethanol injection and radiofrequency ablation for the treatment of hepatocellular carcinoma located immediately under the diaphragm.
Kurokohchi K; Hirai S; Ohgi T; Ono M; Yoshitake A; Ebara K; Kitamura Y; Kasai Y; Maeta T; Kiuchi T; Masaki T; Yoneyama H; Kohi F; Kuriyama S
Int J Oncol; 2006 Aug; 29(2):375-80. PubMed ID: 16820879
[TBL] [Abstract][Full Text] [Related]
25. Survival of patients with early hepatocellular carcinoma treated by percutaneous alcohol injection.
Andriulli A; De Sio I; Brunello F; Salmi A; Solmi L; Facciorusso D; Caturelli E; Perri F
Aliment Pharmacol Ther; 2006 May; 23(9):1329-35. PubMed ID: 16629938
[TBL] [Abstract][Full Text] [Related]
26. [Hepatocellular carcinoma recurrence in PEI site--a case report].
Ota H; Nagano H; Sakon M; Inoue T; Hayashi S; Kondo M; Arai I; Morimoto O; Yamamoto T; Nakamura M; Dono K; Umeshita K; Nakamori S; Wakasa K; Monden M
Gan To Kagaku Ryoho; 2002 Nov; 29(12):2421-4. PubMed ID: 12484090
[TBL] [Abstract][Full Text] [Related]
27. [Hepatocellular carcinoma: local-regional treatment].
Fleig WE
Dtsch Med Wochenschr; 2003 Jun; 128 Suppl 2():S102-3. PubMed ID: 12817337
[No Abstract] [Full Text] [Related]
28. Evaluation of transcatheter arterial embolization prior to percutaneous tumor ablation in patients with hepatocellular carcinoma: a randomized controlled trial.
Akamatsu M; Yoshida H; Obi S; Sato S; Koike Y; Fujishima T; Tateishi R; Imamura M; Hamamura K; Teratani T; Shiina S; Ishikawa T; Omata M
Liver Int; 2004 Dec; 24(6):625-9. PubMed ID: 15566514
[TBL] [Abstract][Full Text] [Related]
29. Interventional treatments for hepatocellular carcinoma.
Guan YS; Liu Y
Hepatobiliary Pancreat Dis Int; 2006 Nov; 5(4):495-500. PubMed ID: 17085331
[TBL] [Abstract][Full Text] [Related]
30. MR-guided percutaneous ethanol ablation of hepatocellular carcinomas before liver transplantation.
Blum M; Mueller C; Peck-Radosavljevic M; Wrba F; Berlakovich G; Mühlbacher F; Steiniger R; Speiser M; Pones M; Hüpfl M; Lammer J; Kettenbach J
Minim Invasive Ther Allied Technol; 2007; 16(4):230-40. PubMed ID: 17763097
[TBL] [Abstract][Full Text] [Related]
31. Efficacy of hepatocellular carcinoma locoregional therapies on patients waiting for liver transplantation.
Moreno Planas JM; López Monclús J; Gómez Cruz A; Rubio González E; Pérez Arangüena R; Boullosa Graña E; Garcia Suárez A; Pérez-Picouto JL; Fernández Ruiz M; Lucena de la Poza JL; Sánchez Turrión V; Cuervas-Mons Martínez V
Transplant Proc; 2005 Apr; 37(3):1484-5. PubMed ID: 15866648
[TBL] [Abstract][Full Text] [Related]
32. Hepatocellular carcinoma and octreotide: treatment results in prospectively assigned patients with advanced tumor and cirrhosis stage.
Plentz RR; Tillmann HL; Kubicka S; Bleck JS; Gebel M; Manns MP; Rudolph KL
J Gastroenterol Hepatol; 2005 Sep; 20(9):1422-8. PubMed ID: 16105131
[TBL] [Abstract][Full Text] [Related]
33. Local ablative therapies in HCC: percutaneous ethanol injection and radiofrequency ablation.
Mahnken AH; Bruners P; Günther RW
Dig Dis; 2009; 27(2):148-56. PubMed ID: 19546553
[TBL] [Abstract][Full Text] [Related]
34. Metal contents of liver parenchyma after percutaneous ethanol injection or radiofrequency ablation in patients with hepatocellular carcinoma before and after trientine hydrochloride therapy.
Fukuda H; Ebara M; Okabe S; Yoshikawa M; Sugiura N; Saisho H; Kondo F; Yukawa M
J Lab Clin Med; 2004 Jun; 143(6):333-9. PubMed ID: 15192648
[TBL] [Abstract][Full Text] [Related]
35. Pleural seeding from hepatocellular carcinoma: a complication of percutaneous alcohol ablation.
Zerbey AL; Mueller PR; Dawson SL; Hoover HC
Radiology; 1994 Oct; 193(1):81-2. PubMed ID: 8090925
[TBL] [Abstract][Full Text] [Related]
36. [Use of autologous tumor vaccine in preventing recurrence of hepatocellular carcinoma].
Peng BG; Liang LJ; He Q; Zhou F; Lai JM; Lü MD; Huang JF
Zhonghua Gan Zang Bing Za Zhi; 2005 Oct; 13(10):772-5. PubMed ID: 16248952
[TBL] [Abstract][Full Text] [Related]
37. [Evaluation of prognosis and recurrence of hepatocellular carcinoma treated from 1988 to 2002 at Department of Medicine III, Kyushu University Hospital].
Arimura E; Nakamuta M; Kotoh K; Morizono S; Fukutomi M; Ohta S; Enjoji M; Sakai H; Nawata H
Fukuoka Igaku Zasshi; 2004 Aug; 95(8):195-200. PubMed ID: 15552961
[TBL] [Abstract][Full Text] [Related]
38. Risk factors of survival after percutaneous radiofrequency ablation of hepatocellular carcinoma.
Peng ZW; Zhang YJ; Chen MS; Liang HH; Li JQ; Zhang YQ; Lau WY
Surg Oncol; 2008 Jul; 17(1):23-31. PubMed ID: 17869095
[TBL] [Abstract][Full Text] [Related]
39. Obesity did not diminish the efficacy of percutaneous ablation for hepatocellular carcinoma.
Ohki T; Tateishi R; Shiina S; Sato T; Masuzaki R; Yoshida H; Kanai F; Obi S; Yoshida H; Omata M
Liver Int; 2007 Apr; 27(3):360-7. PubMed ID: 17355458
[TBL] [Abstract][Full Text] [Related]
40. Survival impact of delayed treatment in patients with hepatocellular carcinoma undergoing locoregional therapy: is there a lead-time bias?
Huo TI; Huang YH; Chiang JH; Wu JC; Lee PC; Chi CW; Lee SD
Scand J Gastroenterol; 2007 Apr; 42(4):485-92. PubMed ID: 17454859
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
